The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients
Abstract
Objective: This study was undertaken to assess the characteristics and outcome of interstitial lung disease (ILD) in polymyositis/dermatomyositis (PM/DM) and to determine variables predictive of ILD deterioration in PM/DM. Methods: Among 348 consecutive patients with PM/DM, 107 patients with ILD were identified by medical records search in 4 medical centers. All patients underwent pulmonary function tests (PFTs) and pulmonary high‐resolution computed tomography (HRCT) scan. Results: ILD onset preceded PM/DM clinical manifestations in 20 patients, was identified concurrently with PM/DM in 69 patients, and occurred after PM/DM onset in 18 patients. Patients with ILD could be divided into 3 groups according to their presenting lung manifestations: patients with acute lung disease (n = 20), patients with progressive‐course lung signs (n = 55), and asymptomatic patients with abnormalities consistent with ILD evident on PFTs and HRCT scan (n = 32). We observed that 32.7% of the patients had resolution of pulmonary disorders, whereas 15.9% experienced ILD deterioration. Factors that predicted a poor ILD prognosis were older age, symptomatic ILD, lower values of vital capacity and diffusing capacity for carbon monoxide, a pattern of usual interstitial pneumonia on HRCT scan and lung biopsy, and steroid‐refractory ILD. The mortality rate was higher in patients with ILD deterioration than in those without ILD deterioration (47.1% versus 3.3%). Conclusion: Our findings indicate that ILD results in high morbidity in PM/DM. Our findings also suggest that more aggressive therapy may be required in PM/DM patients presenting with factors predictive of poor ILD outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Polymyositis and Dermatomyositis: (Second of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920807 · Cited by 2,447
Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies
Connors, G. R., Christopher-Stine, L., Oddis, C. V., & Danoff, S. K. (2010) · Chest · doi:10.1378/chest.10-0180 · Cited by 564
Polymyositis–Dermatomyositis-associated Interstitial Lung Disease
DOUGLAS, W. W., TAZELAAR, H. D., HARTMAN, T. E., HARTMAN, R. P., DECKER, P. A., SCHROEDER, D. R., & RYU, J. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2103110 · Cited by 557
Radiological versus histological diagnosis in UIP and NSIP: survival implications
Flaherty, K. R. (2003) · Thorax · doi:10.1136/thorax.58.2.143 · Cited by 539
Tazelaar, H. D., Viggiano, R. W., Pickersgill, J., & Colby, T. V. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.727 · Cited by 377
Marié, I., HACHULLA, E., Hatron, P., Hellot, M., Levesque, H., Devulder, B., & Courtois, H. (2001) · PubMed · Cited by 287
Self-citationFathi, M., Dastmalchi, M., Rasmussen, E., Lundberg, I. E., & Tornling, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.006122 · Cited by 283
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
Cited by
McHugh, N. J., & Tansley, S. L. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.56 · Cited by 390
Hervier, B., Devilliers, H., Stanciu, R., Meyer, A., Uzunhan, Y., Masseau, A., Dubucquoi, S., Hatron, P.-Y., Musset, L., Wallaert, B., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.06.006 · Cited by 308
Self-citationMaher, T. M., Tudor, V. A., Saunders, P., Gibbons, M. A., Fletcher, S. V., Denton, C. P., Hoyles, R. K., Parfrey, H., Renzoni, E. A., Kokosi, M., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00359-9 · Cited by 290
The natural history of progressive fibrosing interstitial lung diseases
Kolb, M., & Vašáková, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-1022-1 · Cited by 269
Spagnolo, P., Distler, O., Ryerson, C. J., Tzouvelekis, A., Lee, J. S., Bonella, F., Bouros, D., Hoffmann-Vold, A.-M., Crestani, B., & Matteson, E. L. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217230 · Cited by 259
Metadata
- Authors
- Marie, I., Hatron, P. Y., Dominique, S., Cherin, P., Mouthon, L., & Menard, J. ‐.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-10-28
- Volume
- 63
- Issue
- 11
- Pages
- 3439-3447
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2017258499
- Cited by
- 292
- References
- 27
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients. https://app.cochat.ai/papers/10.1002/art.30513
- The paper
- Marie, I., Hatron, P. Y., Dominique, S., Cherin, P., Mouthon, L., & Menard, J. ‐. (2011). Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients. Arthritis & Rheumatism. https://doi.org/10.1002/art.30513
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.